BioMarin Pharmaceutical

United States
Wheeling, West Virginia, United States, 94901

Company profile

BioMarin Pharmaceutical company profile

BioMarin Pharmaceutical develops and delivers therapies for rare genetic and metabolic conditions. The company applies scientific research to understand the underlying causes of diseases and creates medicines using multiple treatment approaches.Its portfolio includes therapies for achondroplasia, severe hemophilia A, and various lysosomal storage disorders. BioMarin conducts clinical and preclinical research to expand its pipeline of investigational treatments. The company emphasizes collaboration with patient communities to inform therapy development and focuses on translating genetic discoveries into potential new medicines. Its operations encompass research, development, and manufacturing of specialized therapies for complex conditions.

Business identity

Contact email
[email protected]
Phone number
+1 415-506-6700
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$100M-$1B
Founded
1997-03-01, Month

Headquarters

Postal code
94901
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Last funding
Post IPO Debt / $3.7B / 2026-01-29
Founders
3
Articles
482
Exited on
1999-07-26

Founders and investors

Founders

Christopher StarrGrant DenisonJohn Klock